[Convalescent plasma as a therapy for severe COVID-19 pneumonia].

The COVID-19 pandemic presented high mortality from its beginning, without effective treatment for seriously ill patients. Build on the experience in Argentine hemorrhagic fever with convalescent plasma, we incorporated 90 patients with COVID-19, of which 87 were evaluable, into a multicenter study. We collected 397 plasma donations from 278 convalescent donors.

[Coagulopathy and COVID-19. Recommendations for a changing reality].

The coronavirus disease 2019 (COVID-19) pandemic requires rapid medical responses. The risk of venous and arterial thromboembolism increases in critically ill patients with SARS-CoV-2 infection. There is a hypercoagulable state that includes elevated levels of D-dimer, with an increased risk of organ failure and increased mortality.

Floating right heart thrombi: A pooled analysis of cases reported over the past 10years.

Introduction: Floating right heart thrombi (FRHTS) are a rare phenomenon associated with high mortality. Immediate treatment is mandatory, but optimal therapy is controversial.

Objective: To compare the clinical characteristics according to different treatment strategies and to identify predictors of mortality on patients with FRHTS.